🔗 Visit the ClinicalTrials.gov page for NCT00523159
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival. | Nat Med | 2012 | 5.44 |
| 2 | Antigen-specific vaccines for cancer treatment. | Hum Vaccin Immunother | 2014 | 0.89 |
| 3 | Trial Watch: Therapeutic vaccines in metastatic renal cell carcinoma. | Oncoimmunology | 2015 | 0.77 |
| 4 | New clinical advances in immunotherapy for the treatment of solid tumours. | Immunology | 2015 | 0.76 |